Tocqueville Asset Management L.P. bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 447,832 shares of the company’s stock, valued at approximately $57,546,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Addison Advisors LLC bought a new position in shares of Merck KGaA in the second quarter valued at approximately $90,000. Comprehensive Financial Planning Inc. PA acquired a new stake in shares of Merck KGaA in the second quarter worth $134,000. Stevens Capital Partners bought a new stake in shares of Merck KGaA during the 2nd quarter worth $220,000. Kelman Lazarov Inc. bought a new stake in shares of Merck KGaA during the 2nd quarter worth $448,000. Finally, BOK Financial Private Wealth Inc. acquired a new position in Merck KGaA in the 2nd quarter valued at $523,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of MKGAF opened at $167.38 on Thursday. The company has a market capitalization of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company’s fifty day moving average price is $162.50 and its 200 day moving average price is $148.28.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
